Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-30T01:08:45.863Z Has data issue: false hasContentIssue false
  • English
  • Français

5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration

Published online by Cambridge University Press:  09 July 2009

G. W. Ashcroft ,
T. B. B. Crawford ,
R. L. Cundall ,
D. L. Davidson ,
Janet Dobson ,
R. C. Dow ,
D. Eccleston ,
R. W. Loose  and
I. A. Pullar
G. W. Ashcroft
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
T. B. B. Crawford
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
R. L. Cundall
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
D. L. Davidson
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
Janet Dobson
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
R. C. Dow
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
D. Eccleston
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
R. W. Loose
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
I. A. Pullar
Affiliation:
From the Medical Research Council Brain Metabolism Unit, University Department of Pharmacology, Edinburgh
Get access Rights & Permissions [Opens in a new window]

Synopsis

L-tryptophan 50 mg/kg was administered orally to patients suffering from either unipolar or bipolar affective illness, and the concentration of 5-hydroxyindol-acetic acid estimated in their cerebrospinal fluid eight hours later. There was no significant difference between the patient groups or between these and patients with neurological disease. These findings suggest a reduced neuronal activity in the 5-hydroxytryptaminergic system in some depressed patients rather than an absolute deficiency of tryptophan-5-hydroxylase. The synthesis of 5-HIAA in response to tryptophan varied with age.

Type
Research Article
Information
Psychological Medicine , Volume 3 , Issue 3 , August 1973 , pp. 326 - 332
Copyright
Copyright © Cambridge University Press 1973

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Ashcroft, G. W., and Sharman, D. F. (1960). 5-Hydroxyindoles in human cerebrospinal fluids. Nature, 186, 1050–1051.CrossRefGoogle ScholarPubMed
Ashcroft, G. W., and Sharman, D. F. (1962). Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. British Journal of Pharmacology, 19, 153–160.Google ScholarPubMed
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., MacDougall, E. J., Stanton, J. B., and Binns, J. K. (1966). 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet, 2, 1049–1052.CrossRefGoogle ScholarPubMed
Ashcroft, G. W., Blackburn, I. M., Eccleston, D., Glen, A. I. M., Hartley, W., Kinloch, N. E., Lonergan, M., Murray, L. G., and Pullar, I. A. (1973). Changes on recovery in the concentrations of the biogenic amines in the c.s.f. of patients with affective illness. Psychological Medicine, 3, 319–325.CrossRefGoogle Scholar
Bowers, M. B. Jr., and Gerbode, A. F. (1968). Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature, 219, 1256–1257.CrossRefGoogle ScholarPubMed
Bulat, M., and Zivković, B. (1971). Origin of 5-hydroxyindoleacetic acid in the spinal fluid. Science, 173, 738–740.CrossRefGoogle Scholar
Dencker, S. J., Malm, U., Roos, B.-E., and Werdinius, B. (1966). Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. Journal of Neurochemistry, 13, 1545–1548.CrossRefGoogle ScholarPubMed
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., Stanton, J. B., Wood, D., and McTurk, P. H. (1970). Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. Journal of Neurology, Neurosurgery and Psychiatry, 33, 269–272.Google ScholarPubMed
Eccleston, D., Ashcroft, G. W., Moir, A. T. B., Parker-Rhodes, A., Lutz, W., and O'Mahoney, D. P. (1968). A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid. Journal of Neurochemistry, 15, 947–957.CrossRefGoogle ScholarPubMed
Guldberg, H. C., and Yates, C. M. (1968). Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid. British Journal of Pharmacology and Chemotherapy, 33, 457–471.CrossRefGoogle Scholar
Guroff, G., and Udenfriend, S. (1962). Studies on aromatic amino acid uptake by rat brain in vivo. Journal of Biological Chemistry 237, 803–806.CrossRefGoogle ScholarPubMed
Hess, S. M., and Udenfriend, S. (1959). A fluorometric procedure for the measurement of tryptamine in tissues. Journal of Pharmacology and Experimental Therapeutics, 127, 175–177.Google ScholarPubMed
Knott, P. J., and Curzon, G. (1972). Free tryptophan in plasma and brain tryptophan metabolism. Nature, 239, 452–453.CrossRefGoogle ScholarPubMed
McMenamy, R. H., Lund, C. C., and Oncley, J. L. (1957). Unbound amino acid concentrations in human blood plasmas. Journal of Clinical Investigation, 36, 1672–1679.CrossRefGoogle ScholarPubMed
Moir, A. T. B., and Eccleston, D. (1968). The effects of precursor loading in the cerebral metabolism of 5-hydroxy-indoles. Journal of Neurochemistry, 15, 1093–1108.CrossRefGoogle Scholar
Praag, H. M. van., Korf, J., and Puite, J. (1970). 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probeneeid. Nature 225, 1259 1260.CrossRefGoogle Scholar
Sheard, M. H., and Aghajanian, G. K. (1968). Stimulation of the midbrain raphe: effect on senotonin metabolism. Journal of Pharmacology and Experimental Therapy, 163, 425–430.Google ScholarPubMed
Shields, P. J., and Eccleston, D. (1972). Effects of electrical stimulation of rat midbrain on 5-hydroxytryptamine synthesis as determined by a sensitive radiosotope method. Journal of Neurochemislry, 19, 265–272.CrossRefGoogle Scholar